Camp4 Therapeutics (CAMP) Cash from Operations (2023 - 2026)
Camp4 Therapeutics (CAMP) reported Cash from Operations of 10981000.0 for Q1 2026, up 23.13% on a YoY basis from 8917887.9 in Q1 2025, and down 275.78% sequentially from 6247000.0 in Q4 2025.
Camp4 Therapeutics (CAMP) Cash from Operations (2023 - 2026) Analysis & Trends
Camp4 Therapeutics (CAMP) has 4 years of Cash from Operations data on file, last reported at 10981000.0 in Q1 2026.
- For the quarter ending Q1 2026, Cash from Operations rose 23.13% year-over-year to 10981000.0; the trailing twelve-month figure through Mar 2026 stood at 26248000.0 (up 46.11% YoY), and the FY2025 full-year result was 29553000.0, up 35.14% from the prior year.
- Cash from Operations fell to 10981000.0 in Q1 2026, from 6247000.0 in the prior quarter.
- In the past five years, Cash from Operations ranged from a high of 6247000.0 in Q4 2025 to a low of 14286000.0 in Q1 2025.
- A 4-year average of 9787900.0 and a median of 11157000.0 in 2024 frame the typical range for Cash from Operations.
- Peak annual rise in Cash from Operations reached 155.34% in 2025, while the deepest fall reached 28.21% in 2025.
- Tracing CAMP's Cash from Operations over 4 years: stood at 11783000.0 in 2023, then increased by 4.2% to 11288000.0 in 2024, then soared by 155.34% to 6247000.0 in 2025, then plunged by 275.78% to 10981000.0 in 2026.
- Business Quant data shows CAMP's Cash from Operations at 10981000.0 in Q1 2026, 6247000.0 in Q4 2025, and 11171000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Operations (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -19.59 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 201.34 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -1.53 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 1.43 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 1.08 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -354.17 Mn |
| 10 | Camp4 Therapeutics | 174.35 Mn | 174.35 Mn | - | -10.98 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -10.98 Mn |
| Mar 31, 2026 | -10.98 Mn |
| Dec 31, 2025 | 6.25 Mn |
| Dec 31, 2025 | 6.25 Mn |
| Sep 30, 2025 | -11.17 Mn |
| Sep 30, 2025 | -11.17 Mn |
| Jun 30, 2025 | -10.34 Mn |
| Jun 30, 2025 | -10.34 Mn |
| Mar 31, 2025 | -14.29 Mn |
| Mar 31, 2025 | -14.29 Mn |
| Dec 31, 2024 | -11.29 Mn |
| Dec 31, 2024 | -11.29 Mn |
| Sep 30, 2024 | -9.69 Mn |
| Sep 30, 2024 | -9.69 Mn |
| Jun 30, 2024 | -13.44 Mn |
| Jun 30, 2024 | -13.44 Mn |
| Mar 31, 2024 | -11.14 Mn |
| Mar 31, 2024 | -11.14 Mn |
| Dec 31, 2023 | -11.78 Mn |
| Dec 31, 2023 | -11.78 Mn |